Create Free Account

By creating account you will get access to hot stocks & personalised emails

Bioxyne Ltd

Consumer Defensive AU BXN

0.006AUD
-0.001(14.29%)

Last update at 2024-05-08T05:13:00Z

Day Range

0.0060.006
LowHigh

52 Week Range

0.0050.03
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -1.96444M -0.23651M -0.42573M -0.59310M -1.36588M
Minority interest - - 0.05M 0.05M 0.05M
Net income -1.96444M -0.23651M -0.42573M -0.59310M -1.13989M
Selling general administrative 2.59M 0.88M 0.83M 0.88M 1.06M
Selling and marketing expenses 0.19M 0.02M 0.04M 0.04M 0.07M
Gross profit 1.90M 1.29M 1.08M 1.22M 1.14M
Reconciled depreciation 0.09M 0.05M 0.05M 0.07M 0.02M
Ebit -2.04243M -0.15332M -0.26962M -0.37360M -1.59187M
Ebitda -1.95584M -0.10327M -0.21972M -0.30179M -1.57280M
Depreciation and amortization 0.09M 0.05M 0.05M 0.07M 0.02M
Non operating income net other - - - - -
Operating income -1.83573M -0.45306M -0.37412M -0.31222M -1.59187M
Other operating expenses 7.27M 0.96M 2.72M 2.96M 3.71M
Interest expense 0.00058M 0.00058M 0.00168M 0.00703M 0.00703M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.00257M 0.02M 0.02M 0.06M 0.14M
Net interest income 0.00257M 0.01M 0.02M 0.03M 0.04M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.00715M 0.04M 0.06M 0.11M -0.22599M
Total revenue 5.16M 2.42M 2.11M 2.26M 2.13M
Total operating expenses 4.04M 1.50M 1.43M 1.73M 2.72M
Cost of revenue 3.26M 1.13M 1.03M 1.04M 0.99M
Total other income expense net 0.09M -0.04376M -0.09470M -0.11193M 0.23M
Discontinued operations - - - - -
Net income from continuing ops -1.96444M -0.23651M -0.42573M -0.59310M -1.26588M
Net income applicable to common shares -1.96444M -0.23651M -0.49573M -0.59310M -1.26588M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 17.69M 2.92M 2.75M 3.34M 3.97M
Intangible assets 0.03M 0.03M 0.03M 0.03M 0.09M
Earning assets - - - - -
Other current assets 0.07M 0.07M 0.05M 0.24M 0.04M
Total liab 2.69M 0.98M 0.74M 0.73M 0.83M
Total stockholder equity 15.14M 1.89M 1.95M 2.56M 3.09M
Deferred long term liab - - - - 0.06M
Other current liab 1.48M 0.89M 0.57M 0.51M 0.40M
Common stock 17.55M 62.18M 62.18M 62.18M 62.18M
Capital stock 17.55M 62.18M 62.18M 62.18M 62.18M
Retained earnings -2.48375M -60.47733M -60.17083M -59.74510M -59.37177M
Other liab - -0.00472M - - -
Good will 11.57M 11.57M - - 0.15M
Other assets - - - - 0.06M
Cash 3.85M 2.17M 1.60M 1.75M 1.77M
Cash and equivalents - - - - -
Total current liabilities 2.69M 0.98M 0.74M 0.73M 0.83M
Current deferred revenue - - -0.04746M -0.48589M -0.04746M
Net debt -3.84597M -2.16801M -1.55475M -1.70042M -1.72045M
Short term debt 0.00000M 0.00000M 0.05M 0.05M 0.05M
Short long term debt - - - - -
Short long term debt total - - 0.05M 0.05M 0.05M
Other stockholder equity -15.06400M 0.19M -1.93671M -2.43243M 0.11M
Property plant equipment 0.09M 0.07M 0.09M 0.17M 0.11M
Total current assets 6.04M 2.82M 2.58M 3.07M 3.52M
Long term investments - - - - -
Net tangible assets 3.57M 1.86M 1.81M 2.46M 2.81M
Short term investments - - - - -
Net receivables 0.90M 0.02M 0.34M 0.30M 0.80M
Long term debt - - - - -
Inventory 0.99M 0.31M 0.44M 0.77M 0.71M
Accounts payable 1.21M 0.10M 0.18M 0.66M 0.43M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.07M 0.19M -0.05575M 0.12M 0.28M
Additional paid in capital - - - - -
Common stock total equity - - - 62.18M 62.18M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -11.65303M - -0.16816M -0.26514M 0.45M
Deferred long term asset charges - - - - -
Non current assets total 11.65M 0.10M 0.17M 0.27M 0.45M
Capital lease obligations - - - 0.05M -
Long term debt total 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments 3.56M -0.00579M - -0.03366M -0.17236M
Change to liabilities 1.81M 0.24M 0.02M -0.15066M 0.10M
Total cashflows from investing activities 3.56M -0.00579M -0.00579M -0.03366M -0.17236M
Net borrowings 0.37M 0.49M -0.04678M -0.05233M -0.05233M
Total cash from financing activities 1.35M -0.04678M -0.04678M -0.05233M -0.05233M
Change to operating activities - - - - -
Net income -1.93997M -0.49402M -0.49573M -0.59310M -1.26588M
Change in cash 3.78M 0.57M -0.14568M -0.02002M -1.54200M
Begin period cash flow 0.07M 1.60M 1.75M 1.77M 3.31M
End period cash flow 3.85M 2.17M 1.60M 1.75M 1.77M
Total cash from operating activities -0.84128M -0.50681M 0.05M 0.05M -1.33804M
Issuance of capital stock 0.58M - - - -
Depreciation 0.11M 0.03M 0.07M 0.10M 0.02M
Other cashflows from investing activities 3.62M 0.09M - 0.00000M -0.10870M
Dividends paid - - - - -
Change to inventory -0.91926M -0.07555M 0.40M -0.05432M -0.08494M
Change to account receivables -0.59549M -0.26558M 0.02M 0.48M -0.24190M
Sale purchase of stock 0.58M 0.00000M - - 0.00000M
Other cashflows from financing activities 0.77M -0.04678M -0.04678M -0.05233M -0.05233M
Change to netincome 0.70M 0.13M 0.03M 0.17M 0.04M
Capital expenditures 0.06M 0.00579M 0.03M 0.03M 0.06M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -1.51475M -0.34113M 0.41M 0.43M 0.23M
Stock based compensation 0.70M 0.10M - - -
Other non cash items 0.99M -0.04351M 0.07M 0.12M 1.27M
Free cash flow -0.89992M -0.51260M 0.02M 0.01M -1.40170M

Fundamentals

  • Previous Close 0.007
  • Market Cap14.33M
  • Volume2822564
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.53633M
  • Revenue TTM7.73M
  • Revenue Per Share TTM0.004
  • Gross Profit TTM 2.04M
  • Diluted EPS TTM-0.01

Peer Comparison

Sector: Consumer Defensive Industry: Packaged Foods

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BXN
Bioxyne Ltd		 -0.001 14.29% 0.006 - - 2.46 6.57 2.02 -5.4776
A2M
A2 Milk Company Ltd		 0.13 2.12% 6.26 31.42 22.12 2.59 4.00 2.24 14.49
BGA
Bega Cheese Ltd		 0.02 0.45% 4.44 - 25.58 0.37 1.24 0.50 -14.1507
CBO
Cobram Estate Olives Ltd		 -0.055 2.93% 1.82 90.50 - 3.68 3.00 4.74 20.80
RIC
Ridley Corporation Ltd		 -0.04 1.82% 2.16 17.15 15.50 0.61 2.41 0.66 9.13

Reports Covered

Stock Research & News

View All

Profile

Bioxyne Limited, a life sciences and consumer health products company, manufactures and distributes consumer health products, patented probiotics, health supplements, therapeutic goods, and alternative medicines in the United Kingdom, Japan, Europe, and Australia. The company manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabinoids, cannabis extracts, vitamins, manuka honey, skin care products, and mushroom complexes. It develops various functional food products, such as ingredients; and lactobacillus fermentum VRI-003 for over-the counter gut health immune supplement products. The company also provides product research and development services, and telemedicine services. In addition, it operates BLS Clinics, a telehealth platform. The company provides its products online, as well as through wholesale and direct sales in the United States and Asia. Bioxyne Limited was incorporated in 1998 and is headquartered in Sydney, Australia.

Bioxyne Ltd

50 Clarence Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Mr. Nam Hoat Chua B.A., BA MD, CEO & Director NA
Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), C.A., CA, MAICD CFO, Company Sec. & Exec. Director 1954
Ms. Rachel Qian Financial Controller & Assistant Company Sec. NA
Mr. Samuel Watson CEO, MD & Executive Director NA
Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICD CFO & Company Secretary 1953
Mr. Jason Hine COO & Executive Director NA
Ms. Rachel Qian Financial Controller & Assistant Company Secretary NA
Mr. Samuel Watson CEO, MD & Executive Director NA
Mr. Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICD CFO & Company Secretary 1953
Mr. Jason Hine COO & Executive Director NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.